Clarivate (CLVT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Core Insights - Clarivate PLC (CLVT) reported revenue of $593.7 million for the quarter ended March 2025, reflecting a year-over-year decline of 4.4% [1] - The earnings per share (EPS) for the same period was $0.14, unchanged from the previous year, with a surprise of +16.67% compared to the consensus estimate of $0.12 [1] - The reported revenue exceeded the Zacks Consensus Estimate of $573.32 million, resulting in a surprise of +3.56% [1] Revenue Breakdown - Intellectual Property revenues were $192.70 million, surpassing the average estimate of $187.39 million, but showing a year-over-year decline of 4.1% [4] - Life Sciences & Healthcare revenues reached $98.30 million, exceeding the average estimate of $90.13 million, with a year-over-year decline of 4.2% [4] - Academia & Government revenues totaled $302.70 million, above the average estimate of $294.34 million, reflecting a year-over-year decline of 4.7% [4] - Transactional and other revenues were reported at $99.20 million, significantly higher than the estimated $63 million, but down 14.2% year-over-year [4] - Re-occurring revenues amounted to $105.90 million, slightly below the average estimate of $107.83 million, showing a year-over-year increase of 3.3% [4] - Subscription revenues were $388.60 million, below the average estimate of $409.15 million, indicating a year-over-year decline of 3.6% [4] Stock Performance - Clarivate's shares have returned -8.7% over the past month, compared to a -0.8% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]